Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer.
Gong WJ, Peng JB, Yin JY, Li XP, Zheng W, Xiao L, Tan LM, Xiao D, Chen YX, Li X, Zhou HH, Liu ZQ. Gong WJ, et al. Acta Pharmacol Sin. 2017 Apr;38(4):581-590. doi: 10.1038/aps.2016.164. Epub 2017 Mar 6. Acta Pharmacol Sin. 2017. PMID: 28260796 Free PMC article.
Circulating resistin levels and obesity-related cancer risk: A meta-analysis.
Gong WJ, Zheng W, Xiao L, Tan LM, Song J, Li XP, Xiao D, Cui JJ, Li X, Zhou HH, Yin JY, Liu ZQ. Gong WJ, et al. Oncotarget. 2016 Sep 6;7(36):57694-57704. doi: 10.18632/oncotarget.11034. Oncotarget. 2016. PMID: 27509174 Free PMC article.
Gene-gene and gene-environment interactions influence platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.
Cui JJ, Wang LY, Zhu T, Gong WJ, Zhou HH, Liu ZQ, Yin JY. Cui JJ, et al. Sci Rep. 2017 Jul 11;7(1):5082. doi: 10.1038/s41598-017-05246-8. Sci Rep. 2017. PMID: 28698656 Free PMC article.
Age-related common miRNA polymorphism associated with severe toxicity in lung cancer patients treated with platinum-based chemotherapy.
Fang C, Li XP, Gong WJ, Wu NY, Tang J, Yin JY, Li X, Zhang W, Zhou HH, Liu ZQ. Fang C, et al. Clin Exp Pharmacol Physiol. 2017 Dec;44 Suppl 1:21-29. doi: 10.1111/1440-1681.12704. Epub 2017 Sep 20. Clin Exp Pharmacol Physiol. 2017. PMID: 27873337
The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients.
Xiao D, Guo Y, Li X, Yin JY, Zheng W, Qiu XW, Xiao L, Liu RR, Wang SY, Gong WJ, Zhou HH, Liu ZQ. Xiao D, et al. Int J Endocrinol. 2016;2016:4350712. doi: 10.1155/2016/4350712. Epub 2016 Feb 10. Int J Endocrinol. 2016. PMID: 26977146 Free PMC article.
Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response.
Gong WJ, Yin JY, Li XP, Fang C, Xiao D, Zhang W, Zhou HH, Li X, Liu ZQ. Gong WJ, et al. Tumour Biol. 2016 Jun;37(6):8349-58. doi: 10.1007/s13277-015-4497-5. Epub 2016 Jan 5. Tumour Biol. 2016. PMID: 26729200
The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients.
Li XP, Yin JY, Wang Y, He H, Li X, Gong WJ, Chen J, Qian CY, Zheng Y, Li F, Yin T, Gong ZC, Zhou BT, Zhang Y, Xiao L, Zhou HH, Liu ZQ. Li XP, et al. Tumour Biol. 2014 Aug;35(8):8259-65. doi: 10.1007/s13277-014-2072-0. Epub 2014 May 23. Tumour Biol. 2014. PMID: 24852429
IL-1B rs1143623 and EEF1A1P11-RPL7P9 rs10783050 polymorphisms affect the glucose-lowing efficacy of metformin in Chinese overweight or obese Type 2 diabetes mellitus patients.
Xiao D, Zhang SM, Li X, Yin JY, Gong WJ, Zheng Y, Xu XJ, Lin X, Ji LN, Liu RR, Tang Q, Zhang W, Zhou HH, Han XY, Liu ZQ. Xiao D, et al. Pharmacogenomics. 2015;16(14):1621-9. doi: 10.2217/pgs.15.95. Epub 2015 Sep 24. Pharmacogenomics. 2015. PMID: 26401715
STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy.
Gong WJ, Ma LY, Hu L, Lv YN, Huang H, Xu JQ, Huang DD, Liu RJ, Han Y, Zhang Y, Shi SJ, Wu SL. Gong WJ, et al. Int J Clin Oncol. 2019 May;24(5):476-484. doi: 10.1007/s10147-018-01386-7. Epub 2019 Jan 28. Int J Clin Oncol. 2019. PMID: 30689078
74 results
Jump to page